Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality

Immune checkpoint inhibitors represent revolutionary anti-cancer agents, being rapidly approved in different malignancies and settings. Gastrointestinal (GI) cancers represent a wide variety of tumors with specific characteristics and different responses to various therapeutic alternatives; while so...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourie, Hampig Raphael, Tabchi, Samer, Ghosn, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423038/
https://www.ncbi.nlm.nih.gov/pubmed/28533658
http://dx.doi.org/10.3748/wjg.v23.i17.3017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423038/
https://www.ncbi.nlm.nih.gov/pubmed/28533658
http://dx.doi.org/10.3748/wjg.v23.i17.3017

Ejemplares similares